GPER1 expression has been detected in multiple cancer types, where it has been the subject of extensive research due to its implications in tumor development, progression, and response to therapies, with effects that can vary depending on the specific cancer type, its microenvironment, and the interplay with tumor-specific signaling pathways [15,17,42,43,44,45]. Here, GPER1 is linked to neoplasm.